Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

On Location

Updates from major medical meetings in the field of hematology/oncology
Fertility Preservation Initiative Improves Referrals in a Community Oncology Practice
AP-Led Initiative Builds Best Practice for Oral Antineoplastic Therapy Programs
AP Leadership, Achievements Increase Satisfaction, Reduce Burnout
Study Suggests Potential Racial, Ethnic Differences in Response Rates to CAR-T Therapy in R/R MM
Ide-Cel Yields Strong Responses When Used Earlier
Innate Cell Engager AFM13 Combined With Preactivated and Expanded Cord Blood-Derived NK Cells Targets CD30+ Lymphoma
Emicizumab Can Be Used Without FVIII Inhibitors in Infants With Severe Hemophilia
Study Reveals Approach to Testing Adolescent Girls for VWD
Incorporation of Ibrutinib in First-Line Treatment of MCL May Eliminate Need for AHCT
Polatuzumab Vedotin Improves Response Rates in R/R DLBCL When Added to Standard Therapy
TA More Effective, Affordable Than rVWF for VWD-Related Heavy Menstrual Bleeding
Elranatamab Induces Clinical and Molecular Responses in R/R MM
Dalteparin to Apixaban for Upper Extremity DVT in Patients with Cancer
Ruxolitinib Plus Dexamethasone Improves Outcomes in HLH
Better Recognition Needed for Early Diagnosis of hTTP
Protective Diet Does Not Benefit Patients Receiving HT Compared to Non-Restricted Diet
GPRC5D-Targeting Bispecific Antibody Talquetamab Promising in R/R Multiple Myeloma
Racial and Socioeconomic Disparities Persist in US-Based PE Care and Outcomes
Frontline Chemo-Free Triplet Yields High Rates of MRD-Negative Complete Remission in MCL
Degrader Molecule Helps Eliminate BTK in Patients With BTK Mutations

Advertisement

Connect with us:

CURRENT ISSUE
March 2023

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright ©2023 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement